The FDA awarded 11 grants to support research into rare diseases, including cancers.

A grieving mother shares her frustration and anguish at being denied access to her daughter’s medical records after the 3-year-old girl died of a brain tumor. (Journal of Clinical Oncology)

Merck has announced the FDA approval of pembrolizumab (Keytruda) in combination with chemotherapy, with or without bevacizumab, for the first-line treatment of persistent, recurrent or metastatic PD-L1 positive cervical cancer.

Allogene announced that the FDA has suspended all clinical trials of the company’s CAR T cell products after a patient developed chromosomal abnormalities of undetermined significance in CAR T cells.

A public / private initiative in Europe will invest around $ 25 million to integrate artificial intelligence-based technology into clinical decision-making for prostate, lung and breast cancer. (European Association of Urology)

Many women may be screened for cervical cancer more often than recommended. (University of New Mexico Health Sciences Center)

Patients with breast cancer often use cannabis before, during and after treatment without telling their doctor. (Cancer)

Solving the mysterious lack of T-cell lymphomas in HIV-infected patients. (University of Pittsburgh Medical Center)

The FDA announced the first three authorized e-cigarette products through its pre-market tobacco product application channel, but denied the flavored product applications.

Walgreens’ new CEO promises “real control” over tobacco sales as the company steps up its focus on healthcare. (CNBC)

A so-called “non-drug” cancer protein has succumbed to an experimental small molecule protein degrader in animal models of brain, breast, lung and colon cancer. (FerociousPharma)

  • Charles Bankhead is Editor-in-Chief for Oncology and also covers Urology, Dermatology and Ophthalmology. He joined MedPage Today in 2007. To follow



Source link